VERIGAT 5 mg is a tablet containing vericiguat 5 mg. It is a soluble guanylate cyclase (sGC) stimulator used to reduce the risk of cardiovascular death and hospitalization in adults with symptomatic chronic heart failure and reduced ejection fraction after a recent worsening of heart failure.
Uses:
Treatment of chronic heart failure with reduced ejection fraction (HFrEF)
Helps reduce the risk of cardiovascular death
Helps reduce hospitalization due to worsening heart failure
Improves heart function and exercise capacity in eligible patients
Dose:
Adults: Usually started at 2.5 mg once daily, then increased to 5 mg once daily as tolerated, or as directed by a physician
May be increased to a maximum of 10 mg once daily based on patient response
Take with food
Swallow the tablet whole with water
Follow the prescribed dose and duration as advised by a healthcare professional